FR2316933B1 - - Google Patents

Info

Publication number
FR2316933B1
FR2316933B1 FR7620325A FR7620325A FR2316933B1 FR 2316933 B1 FR2316933 B1 FR 2316933B1 FR 7620325 A FR7620325 A FR 7620325A FR 7620325 A FR7620325 A FR 7620325A FR 2316933 B1 FR2316933 B1 FR 2316933B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7620325A
Other languages
French (fr)
Other versions
FR2316933A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Original Assignee
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG filed Critical Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Publication of FR2316933A1 publication Critical patent/FR2316933A1/fr
Application granted granted Critical
Publication of FR2316933B1 publication Critical patent/FR2316933B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7620325A 1975-07-07 1976-07-02 Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. Granted FR2316933A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752530246 DE2530246A1 (de) 1975-07-07 1975-07-07 L-aminosaeuregemische fuer parenterale oder orale anwendung

Publications (2)

Publication Number Publication Date
FR2316933A1 FR2316933A1 (fr) 1977-02-04
FR2316933B1 true FR2316933B1 (en:Method) 1979-06-29

Family

ID=5950870

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7620325A Granted FR2316933A1 (fr) 1975-07-07 1976-07-02 Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Country Status (2)

Country Link
DE (1) DE2530246A1 (en:Method)
FR (1) FR2316933A1 (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung
JPS5535049A (en) * 1978-09-04 1980-03-11 Otsuka Pharmaceut Factory Inc Amino acid transfusion for cancerous patient
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
JPS5916817A (ja) * 1982-07-16 1984-01-28 Eisai Co Ltd アミノ酸輸液
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
IT1289754B1 (it) * 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1667887C2 (de) * 1968-02-09 1978-09-28 Knauff, Hans Georg, Prof. Dr., 3551 Dagobertshausen Aminosäurelösung zur parenteralen Infusion
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
FR2215212B1 (en:Method) * 1973-01-18 1976-03-05 Seperic Ch
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body

Also Published As

Publication number Publication date
DE2530246A1 (de) 1977-01-13
DE2530246C2 (en:Method) 1989-08-03
FR2316933A1 (fr) 1977-02-04

Similar Documents

Publication Publication Date Title
AU1385876A (en:Method)
JPS54134411U (en:Method)
JPS5190752A (en:Method)
FR2316933B1 (en:Method)
JPS5754752B2 (en:Method)
JPS5198986A (en:Method)
JPS5279333U (en:Method)
JPS5240355U (en:Method)
AR204567A1 (en:Method)
JPS5536107Y2 (en:Method)
JPS542842Y2 (en:Method)
JPS5282884U (en:Method)
JPS5246156U (en:Method)
JPS5271272U (en:Method)
JPS5193810U (en:Method)
JPS51151774U (en:Method)
CH582816A5 (en:Method)
CH590048A5 (en:Method)
CH586763A5 (en:Method)
CH585518A5 (en:Method)
CH585088A5 (en:Method)
CH584779A5 (en:Method)
CH599351A5 (en:Method)
CH583534A5 (en:Method)
CH595189A5 (en:Method)